Table 1.
General characteristics of T2DM patients at baseline
| Variable | Taurine group (n = 26) | Placebo group (n = 24) | P-value |
|---|---|---|---|
| Age (years)b | 42.04 ± 6.37 | 44.17 ± 658 | 0.252d |
| Sex (n/%) | 0.630c | ||
| Male (n/%)a | 7 (26.9) | 7 (33.3) | |
| Female (n/%)a | 19 (73.1) | 16 (66.7) | |
| Duration of T2DM, yearsb | 3.85 ± 1.58 | 3.25 ± 1.30 | 0.212d |
| Family history of diabetes (%)a | 11 (42.3) | 9 (37.5) | 0.828d |
| Metformin use, n (%)a | 24 (92.3) | 22 (91.7) | 0.935c |
| Glibenclamide use, n (%)a | 8 (30.8) | 6 (25) | 0.658c |
| Weight (kg)b | 80.21 ± 8.49 | 78.90 ± 11.7 | 0.657d |
| BMI (kg/m2)b | 30.62 ± 3.98 | 30.25 ± 2.66 | 0.699d |
| WC (cm)b | 100.53 ± 7.01 | 101.25 ± 6.28 | 0.708d |
| FBS (mg/dL)b | 168.37 (16.33) | 174.22 (19.79) | 0.259d |
| HbA1C, %b | 6.97 (0.71) | 7.26 (0.91) | 0.215d |
| Insulin, mU/mLb | 10.66 (3.17) | 11.70 (3.60) | 0.340d |
| Physical activity | |||
| Low (%)a | 11 (42.3) | 14 (58.3) | 0.511 |
| Moderate (%)a | 14 (53.8) | 8 (33.3) | |
| High (%)a | 1 (4.3) | 2 (8.3) | |
T2DM: Type 2 Diabetes Mellitus; BMI: Body Mass Index; WC: Waist Circumference; FBS: Fasting Blood Sugar
aValues are expressed as frequency (%)
bValues are expressed as mean (SD)
cChi square test
dIndependent samples t-test